Compare, Analyse Pfizer with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ACTAVIS (US) - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ACTAVIS
EQUITY SHARE DATA
    PFIZER
Mar-19
ACTAVIS
Dec-18
PFIZER/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,84014,760-   
Low Rs2,0809,901-   
Sales per share (Unadj.) Rs455.03,620.7-  
Earnings per share (Unadj.) Rs93.8-1,166.2-  
Cash flow per share (Unadj.) Rs109.4381.5-  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.214,933.5-  
Shares outstanding (eoy) m45.75332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.53.4 191.0%   
Avg P/E ratio x31.6-10.6 -298.5%  
P/CF ratio (eoy) x27.132.3 83.7%  
Price / Book Value ratio x4.50.8 544.6%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,4204,101,178 3.3%   
No. of employees `0002.616.9 15.6%   
Total wages/salary Rs m3,2380-   
Avg. sales/employee Rs Th7,911.471,256.4 11.1%   
Avg. wages/employee Rs Th1,230.90-   
Avg. net profit/employee Rs Th1,630.7-22,951.7 -7.1%   
INCOME DATA
Net Sales Rs m20,8151,204,232 1.7%  
Other income Rs m1,67423,029 7.3%   
Total revenues Rs m22,4891,227,261 1.8%   
Gross profit Rs m5,71231,557 18.1%  
Depreciation Rs m714514,783 0.1%   
Interest Rs m7369,491 0.1%   
Profit before tax Rs m6,599-529,688 -1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0135,092 0.0%   
Tax Rs m2,309-6,713 -34.4%   
Profit after tax Rs m4,291-387,884 -1.1%  
Gross profit margin %27.42.6 1,047.2%  
Effective tax rate %35.01.3 2,760.5%   
Net profit margin %20.6-32.2 -64.0%  
BALANCE SHEET DATA
Current assets Rs m27,167493,913 5.5%   
Current liabilities Rs m8,917436,932 2.0%   
Net working cap to sales %87.74.7 1,852.9%  
Current ratio x3.01.1 269.5%  
Inventory Days Days6820 346.2%  
Debtors Days Days3066 45.4%  
Net fixed assets Rs m8,862136,312 6.5%   
Share capital Rs m4580-   
"Free" reserves Rs m29,6560-   
Net worth Rs m30,1134,966,896 0.6%   
Long term debt Rs m251,749,024 0.0%   
Total assets Rs m39,4007,764,389 0.5%  
Interest coverage x91.5-6.6 -1,382.0%   
Debt to equity ratio x00.4 0.2%  
Sales to assets ratio x0.50.2 340.6%   
Return on assets %11.1-4.1 -270.1%  
Return on equity %14.2-7.8 -182.4%  
Return on capital %22.1-4.8 -457.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3580-   
CASH FLOW
From Operations Rs m978430,227 0.2%  
From Investments Rs m351236,354 0.1%  
From Financial Activity Rs m-1,099-738,398 0.1%  
Net Cashflow Rs m231-71,459 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 76.28 Rs / USD

Compare PFIZER With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PFIZER With: TTK HEALTHCARE  ORCHID PHARMA LTD  J.B.CHEMICALS  SHASUN PHARMA  WYETH LTD  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views On News

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

PFIZER SHARE PRICE


Apr 3, 2020 (Close)

TRACK PFIZER

MORE ON PFIZER

PFIZER 5-YR ANALYSIS

COMPARE PFIZER WITH

OTHER USEFUL LINKS

MARKET STATS